Status:
COMPLETED
Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
The primary goal is to evaluate whether a home telehealth system that enables the participant to monitor their body weight, blood glucose values and blood pressure values, associated with remote educa...
Eligibility Criteria
Inclusion
- has type 2 diabetes
- treated with oral agents in monotherapy or combined therapy ± basal insulin
- previously educated to self-monitoring blood glucose (SMBG) use
Exclusion
- has type 2 diabetes non-pharmacologically treated
- has type 2 diabetes treated with multiple daily injections of insulin
- is unable to use the telemedicine system
- pregnancy
- has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
- has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2013
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02194608
Start Date
December 1 2011
End Date
July 1 2013
Last Update
June 24 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.